Navigation Links
GeneTex Launches New Antibody Against Phosphorylated Histone H3 for Epigenetics Research
Date:12/10/2012

IRVINE, Calif., Dec. 10, 2012 /PRNewswire/ -- GeneTex, a leading manufacturer of antibodies and antibody-related reagents, is set to launch a new antibody against phosphorylated Histone H3. Histone proteins package and organize the DNA of eukaryotic cells into structural units referred to as nucleosomes, and the modification of histone tails plays a critical role in the modulation of gene transcription.

(Photo:  http://photos.prnewswire.com/prnh/20121210/LA26278)

(Logo:  http://photos.prnewswire.com/prnh/20111129/LA13485LOGO-b)

The phosphorylation of Histone H3 at serine residue 10 by Msk1 during interphase marks transcriptional activation. Aurora kinase B also phosphorylates Ser10, along with Ser28, at the onset of mitosis to initiate chromosome condensation. More recent evidence suggests that the phosphorylation of Histone H3 at Ser10 stimulates Lys14 acetylation and may also act as a "master switch" that prevents the abnormal phosphorylation of Histone H3 at other sites during mitosis.

GeneTex's new Histone H3 (phospho Ser10) antibody will allow researchers to further examine the role that histone phosphorylation plays in complex epigenetic processes. The antibody has been validated for western blotting in both human and mouse samples as well as for immunocytochemistry/immunofluorescence. For additional information on GeneTex, Inc. and its epigenetics antibodies, please call toll-free 877-GENETEX (436-3839) or visit www.genetex.com.

About GeneTex, Inc.

GeneTex, Inc. is an antibody company founded in 1997 by a group of internationally renowned scientists from academia. They strive to produce the highest quality antibodies and reagents. Their primary and secondary antibodies are created through a process involving extensive research, development and validation. GeneTex's catalog has grown to over 55,000 primary antibodies and all are backed by a 100% Satisfaction Guarantee. 

Corporate Mission

We strive to serve and accelerate life science research by creating essential life science tools where quality can be found in every vial.


'/>"/>
SOURCE GeneTex
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. GeneTex Antibody Company to Launch New Line of Primary Antibodies for the Study of Spindle Assembly
2. GeneTex, Inc. to Attend the 2012 Annual Meeting of the American Society for Cell Biology
3. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
4. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
5. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
6. Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
7. Neogen Launches Fully Quantitative Lateral Flow Test for DON
8. Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic
9. iHealth Lab Launches Personalized Web Portal to Store Your Vitals
10. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
11. Upsher-Smith Launches B-Nexa® Prescription Prenatal Vitamin With B Vitamins and Ginger for Nausea and Vomiting of Pregnancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a global contract research, ... improve patient outcomes and quality of life, will now be offering its impurity ... to new regulatory requirements for all new drug products, including the finalization of ...
(Date:10/11/2017)... ... October 11, 2017 , ... Personal eye wash is a basic first aid supply for any ... So which eye do you rinse first if a dangerous substance enters both eyes? It’s ... Wash with its unique dual eye piece. , “Whether its dirt and debris, or ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... DIEGO, CALIF. (PRWEB) , ... October 10, 2017 , ... ... as part of its corporate rebranding initiative announced today. The bold new look ... its reach, as the company moves into a significant growth period. , It will ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... April 11, 2017 No two people ... at the New York University Tandon School of ... have found that partial similarities between prints are ... in mobile phones and other electronic devices can ... The vulnerability lies in the fact that fingerprint-based ...
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
Breaking Biology News(10 mins):